Canopy Growth Corporation (CGC) |
|
1.9 -0.01 (-0.52%)
|
03-24 16:00 |
|
Open: |
1.91 |
Pre. Close: |
1.91 |
|
High:
|
1.93 |
Low:
|
1.8792 |
|
Volume:
|
4,005,382 |
Market Cap:
|
940(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:24:48 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 2.63  One year: 2.93 |
| Support: |
Support1: 1.85 Support2: 1.53 |
| Resistance: |
Resistance1: 2.25 Resistance2: 2.5 |
| Pivot: |
2.03 |
| Moving Average: |
MA(5): 1.9 MA(20): 2.09
MA(100): 2.77 MA(250): 3.48 |
| MACD: |
MACD(12,26): -0.2  Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 10.1 %D(3): 12 |
| RSI: |
RSI(14): 33.1 |
| 52-week: |
High: 8.06 Low: 1.85 |
| Average Vol(K): |
3-Month: 7,547 (K) 10-Days: 5,953 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CGC ] has closed above bottom band by 21.3%. Bollinger Bands are 56.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.93 - 1.94 |
1.94 - 1.95 |
|
Low:
|
1.85 - 1.87 |
1.87 - 1.88 |
|
Close:
|
1.88 - 1.9 |
1.9 - 1.92 |
|
Company Description |
|
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada. |
Headline News |
Fri, 24 Mar 2023
Wana CEO Whiteman challenges entrepreneurs to 'grow the pie' for cannabis - MarketWatch
Thu, 23 Mar 2023
Where Does Wall Street Think Canopy Growth Corp (CGC) Stock Will Go? - InvestorsObserver
Tue, 21 Mar 2023
TLRY: Sell the Farm on These 4 Cannabis Stocks - StockNews.com
Tue, 21 Mar 2023
Acreage wins approval from British Columbia for Canopy Growth transaction and extends the exercise date by 60 days - MarketWatch
Mon, 20 Mar 2023
Unusual Put Option Trade in Canopy Growth (CGC) Worth $55.81K - Nasdaq
Mon, 20 Mar 2023
CGC stock, ACB and OGI stocks hit 52-week lows - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
495 (M) |
| Shares Float |
323 (M) |
|
% Held by Insiders
|
34.7 (%) |
|
% Held by Institutions
|
15.2 (%) |
|
Shares Short
|
49,100 (K) |
|
Shares Short P.Month
|
53,760 (K) |
Stock Financials |
|
EPS
|
-5 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
2.88 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-115 |
|
Return on Assets (ttm)
|
-6.8 |
|
Return on Equity (ttm)
|
-112 |
|
Qtrly Rev. Growth
|
-28.3 |
|
Gross Profit (p.s.)
|
-0.17 |
|
Sales Per Share
|
0.89 |
|
EBITDA (p.s.)
|
-0.84 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-544 (M) |
|
Levered Free Cash Flow
|
-104 (M) |
Stock Valuations |
|
PE Ratio
|
-0.38 |
|
PEG Ratio
|
-0.2 |
|
Price to Book value
|
0.65 |
|
Price to Sales
|
2.13 |
|
Price to Cash Flow
|
-1.73 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
